Laboratory Corporation of America Holdings Cash Flow Conversion Efficiency
Laboratory Corporation of America Holdings cash flow conversion efficiency. Based on the latest financial reports, Laboratory Corporation of America Holdings (LH) has a cash flow conversion efficiency ratio of 0.022x as of March 2026. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow ($191.50 Million) by net assets ($8.75 Billion). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.
Cash Flow Conversion Efficiency of Laboratory Corporation of America Holdings (1989–2025)
Cash flow conversion efficiency of Laboratory Corporation of America Holdings from 1989 to 2025. This chart illustrates how Laboratory Corporation of America Holdings's cash flow conversion efficiency has evolved over time, based on yearly financial data. View today's stock price for Laboratory Corporation of America Holdin for real-time trading data and today's change.
Laboratory Corporation of America Holdings Cash Flow Conversion Ratio Explained
Laboratory Corporation of America Holdings cash flow conversion ratio divides operating cash flow by net assets, so a higher ratio means more cash generated from each unit of shareholder equity.
Laboratory Corporation of America Holdings Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Laboratory Corporation of America Holdings ranked by their cash flow conversion efficiency. Also see LH stock market capitalisation for the company's overall valuation and market capitalisation.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Credicorp Ltd
F:D8V
|
-0.019x |
|
Grupo Carso S.A.B. de C.V
MX:GCARSOA1
|
-0.002x |
|
VONOVIA SE ADR 1/2/O.N
F:VNAA
|
0.011x |
|
Bridgestone Corporation
F:BGTA
|
0.022x |
|
CMS Energy Corporation
NYSE:CMS
|
0.060x |
|
Hua Nan Financial Holdings Co Ltd
TW:2880
|
-0.595x |
|
First Solar Inc
NASDAQ:FSLR
|
-0.022x |
|
EAST JP RAILW. ADR 1/6
F:EJR0
|
N/A |
Annual Cash Flow Conversion Efficiency for Laboratory Corporation of America Holdings (1989–2025)
The table below shows the annual cash flow conversion efficiency of Laboratory Corporation of America Holdings from 1989 to 2025. Review LH free cash flow to operating cash ratio to assess how much free cash flow the company generates relative to operating cash flow.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2025-12-31 | $8.64 Billion | $1.64 Billion | 0.190x | -3.38% |
| 2024-12-31 | $8.07 Billion | $1.59 Billion | 0.197x | +16.83% |
| 2023-12-31 | $7.89 Billion | $1.33 Billion | 0.168x | -12.98% |
| 2022-12-31 | $10.12 Billion | $1.96 Billion | 0.193x | -35.99% |
| 2021-12-31 | $10.29 Billion | $3.11 Billion | 0.302x | +33.79% |
| 2020-12-31 | $9.46 Billion | $2.14 Billion | 0.226x | +18.18% |
| 2019-12-31 | $7.56 Billion | $1.44 Billion | 0.191x | +2.31% |
| 2018-12-31 | $6.99 Billion | $1.31 Billion | 0.187x | -14.01% |
| 2017-12-31 | $6.72 Billion | $1.46 Billion | 0.217x | +1.97% |
| 2016-12-31 | $5.52 Billion | $1.18 Billion | 0.213x | +11.47% |
| 2015-12-31 | $5.14 Billion | $982.40 Million | 0.191x | -26.62% |
| 2014-12-31 | $2.84 Billion | $739.00 Million | 0.260x | -21.09% |
| 2013-12-31 | $2.48 Billion | $818.70 Million | 0.330x | +7.95% |
| 2012-12-31 | $2.75 Billion | $841.40 Million | 0.306x | -9.84% |
| 2011-12-31 | $2.52 Billion | $855.60 Million | 0.339x | +1.10% |
| 2010-12-31 | $2.63 Billion | $883.60 Million | 0.335x | -12.57% |
| 2009-12-31 | $2.25 Billion | $862.40 Million | 0.384x | -11.12% |
| 2008-12-31 | $1.81 Billion | $780.90 Million | 0.432x | +4.91% |
| 2007-12-31 | $1.73 Billion | $709.70 Million | 0.411x | +28.62% |
| 2006-12-31 | $1.98 Billion | $632.30 Million | 0.320x | +5.03% |
| 2005-12-31 | $1.89 Billion | $574.20 Million | 0.305x | +11.71% |
| 2004-12-31 | $1.97 Billion | $538.10 Million | 0.273x | -8.42% |
| 2003-12-31 | $1.90 Billion | $564.30 Million | 0.298x | +9.92% |
| 2002-12-31 | $1.64 Billion | $444.90 Million | 0.271x | -7.00% |
| 2001-12-31 | $1.09 Billion | $316.00 Million | 0.291x | +3.54% |
| 2000-12-31 | $877.40 Million | $246.70 Million | 0.281x | +14.37% |
| 1999-12-31 | $734.20 Million | $180.50 Million | 0.246x | +33.87% |
| 1998-12-31 | $681.20 Million | $125.10 Million | 0.184x | -19.88% |
| 1997-12-31 | $630.00 Million | $144.40 Million | 0.229x | +131.67% |
| 1996-12-31 | $258.10 Million | $-186.80 Million | -0.724x | -733.82% |
| 1995-12-31 | $411.60 Million | $47.00 Million | 0.114x | +28.95% |
| 1994-12-31 | $166.00 Million | $14.70 Million | 0.089x | -78.20% |
| 1993-12-31 | $140.80 Million | $57.20 Million | 0.406x | -14.36% |
| 1992-12-31 | $212.50 Million | $100.80 Million | 0.474x | +17.10% |
| 1991-12-31 | $330.80 Million | $134.00 Million | 0.405x | -7.49% |
| 1990-12-31 | $256.70 Million | $112.40 Million | 0.438x | +101.25% |
| 1989-12-31 | $330.00 Million | $71.80 Million | 0.218x | -- |
About Laboratory Corporation of America Holdings
Labcorp Holdings Inc. provides laboratory services. It operates through two segments, Diagnostics Laboratories and Biopharma Laboratory Services. The company offers various tests, such as blood chemistry analyses, urinalyses, blood cell counts, thyroid tests, PAP tests, hemoglobin A1C, PSA, tests for sexually transmitted diseases, vitamin D testing, microbiology cultures and procedures, and alcoh… Read more